Mikaela L Garland1, Hamish S Mace2, Andrew D MacCormick3, Stuart A McCluskey4, Nicholas J Lightfoot5. 1. Department of Anaesthesia and Pain Medicine, Middlemore Hospital, 100 Hospital Road, Otahuhu, Auckland, 2025, New Zealand. mikaela.garland@gmail.com. 2. Department of Anaesthesia and Pain Medicine, Fiona Stanley Hospital, 11 Robin Warren Drive, Murdoch, WA, 6150, Australia. 3. Department of Surgery, Middlemore Hospital, 100 Hospital Road, Otahuhu, Auckland, 2025, New Zealand. 4. Department of Anaesthesia and Pain Management, University Health Network, 190 Elizabeth Street, Toronto, ON, M5G 2C4, Canada. 5. Department of Anaesthesia and Pain Medicine, Middlemore Hospital, 100 Hospital Road, Otahuhu, Auckland, 2025, New Zealand.
Abstract
BACKGROUND: Pancreaticoduodenectomy is associated with significant morbidity and mortality which may be influenced by perioperative fluid management. It remains unclear whether liberal and restrictive fluid regimens impact mortality and morbidity in patients undergoing pancreaticoduodenectomy. METHODS: Medline, EMBASE, Cochrane Library and clinicaltrials.gov were searched for studies comparing restrictive and liberal perioperative fluids in patients undergoing pancreaticoduodenectomy. Both prospective and retrospective studies in those undergoing pancreaticoduodenectomy were eligible for inclusion where the patient outcomes were stratified to restrictive and liberal perioperative fluid management regimens, with mortality as the primary outcome. Following study identification, a systematic review and meta-analysis with trial sequential analysis was completed. RESULTS: Thirteen studies including five prospective trials and eight retrospective analyses totalling 3062 patients were included. Restrictive fluid regimens were associated with a significant reduction in mortality compared to liberal fluid regimens for the overall cohort (odds ratio 0.54; 95% CI 0.31-0.94, p = 0.03). There were no significant differences in complication profile. Subgroup analysis revealed this result was contributed to significantly by retrospective studies. The results of the trial sequential analysis suggest this mortality benefit may be due to a type I statistical error and that further patient numbers are required for definitive conclusions. CONCLUSIONS: Restrictive fluid regimens are associated with a reduction in mortality following pancreaticoduodenectomy. The clinical relevance of this finding needs to be interpreted pragmatically given the lack of association with significant causes of morbidity and in considering the results of the recently published RELIEF study.
BACKGROUND: Pancreaticoduodenectomy is associated with significant morbidity and mortality which may be influenced by perioperative fluid management. It remains unclear whether liberal and restrictive fluid regimens impact mortality and morbidity in patients undergoing pancreaticoduodenectomy. METHODS: Medline, EMBASE, Cochrane Library and clinicaltrials.gov were searched for studies comparing restrictive and liberal perioperative fluids in patients undergoing pancreaticoduodenectomy. Both prospective and retrospective studies in those undergoing pancreaticoduodenectomy were eligible for inclusion where the patient outcomes were stratified to restrictive and liberal perioperative fluid management regimens, with mortality as the primary outcome. Following study identification, a systematic review and meta-analysis with trial sequential analysis was completed. RESULTS: Thirteen studies including five prospective trials and eight retrospective analyses totalling 3062 patients were included. Restrictive fluid regimens were associated with a significant reduction in mortality compared to liberal fluid regimens for the overall cohort (odds ratio 0.54; 95% CI 0.31-0.94, p = 0.03). There were no significant differences in complication profile. Subgroup analysis revealed this result was contributed to significantly by retrospective studies. The results of the trial sequential analysis suggest this mortality benefit may be due to a type I statistical error and that further patient numbers are required for definitive conclusions. CONCLUSIONS: Restrictive fluid regimens are associated with a reduction in mortality following pancreaticoduodenectomy. The clinical relevance of this finding needs to be interpreted pragmatically given the lack of association with significant causes of morbidity and in considering the results of the recently published RELIEF study.
Authors: Birgitte Brandstrup; Hanne Tønnesen; Randi Beier-Holgersen; Else Hjortsø; Helle Ørding; Karen Lindorff-Larsen; Morten S Rasmussen; Charlotte Lanng; Lene Wallin; Lene H Iversen; Christina S Gramkow; Mette Okholm; Tine Blemmer; Poul-Erik Svendsen; Henrik H Rottensten; Birgit Thage; Jens Riis; Inge S Jeppesen; Dorthe Teilum; Anne Mette Christensen; Ben Graungaard; Frank Pott Journal: Ann Surg Date: 2003-11 Impact factor: 12.969
Authors: N Tjarda van Heek; Koert F D Kuhlmann; Rob J Scholten; Steve M M de Castro; Olivier R C Busch; Thomas M van Gulik; Huug Obertop; Dirk J Gouma Journal: Ann Surg Date: 2005-12 Impact factor: 12.969
Authors: J Wind; S W Polle; P H P Fung Kon Jin; C H C Dejong; M F von Meyenfeldt; D T Ubbink; D J Gouma; W A Bemelman Journal: Br J Surg Date: 2006-07 Impact factor: 6.939
Authors: Dileep N Lobo; Kate A Bostock; Keith R Neal; Alan C Perkins; Brian J Rowlands; Simon P Allison Journal: Lancet Date: 2002-05-25 Impact factor: 79.321